DK516385D0 - Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter - Google Patents
Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanterInfo
- Publication number
- DK516385D0 DK516385D0 DK516385A DK516385A DK516385D0 DK 516385 D0 DK516385 D0 DK 516385D0 DK 516385 A DK516385 A DK 516385A DK 516385 A DK516385 A DK 516385A DK 516385 D0 DK516385 D0 DK 516385D0
- Authority
- DK
- Denmark
- Prior art keywords
- cell
- bcel
- determinants
- against hepatitis
- vaccine against
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title abstract 3
- 229940126577 synthetic vaccine Drugs 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 101710118982 Pathogen-related protein Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000001541 thymus gland Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Selective Calling Equipment (AREA)
- Air Bags (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/588,122 US4599230A (en) | 1984-03-09 | 1984-03-09 | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
US06/587,983 US4599231A (en) | 1984-03-09 | 1984-03-09 | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
PCT/US1985/000360 WO1985004103A1 (en) | 1984-03-09 | 1985-03-06 | Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
Publications (2)
Publication Number | Publication Date |
---|---|
DK516385A DK516385A (da) | 1985-11-08 |
DK516385D0 true DK516385D0 (da) | 1985-11-08 |
Family
ID=27080174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK516385A DK516385D0 (da) | 1984-03-09 | 1985-11-08 | Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0155146B1 (fi) |
AT (1) | ATE82135T1 (fi) |
AU (2) | AU579148B2 (fi) |
CA (1) | CA1253069A (fi) |
DE (1) | DE3586801D1 (fi) |
DK (1) | DK516385D0 (fi) |
FI (1) | FI84558C (fi) |
IL (3) | IL90035A (fi) |
NO (1) | NO167359C (fi) |
NZ (2) | NZ211356A (fi) |
WO (1) | WO1985004103A1 (fi) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2560890B1 (fr) * | 1984-03-07 | 1987-10-16 | Grp Genie Genetique | Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention |
JPH01500515A (ja) * | 1986-06-20 | 1989-02-23 | スクリップス クリニック アンド リサーチ ファウンデーション | B型肝炎ウィルス表面抗原のプレs領域のt及びb細胞エピトープ |
US6054438A (en) * | 1987-01-07 | 2000-04-25 | Imperial Cancer Research Technology Limited | Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
AU1668788A (en) * | 1987-05-26 | 1988-12-01 | Wistar Institute, The | Method of vaccination for hepatitis b virus |
ES2167304T3 (es) * | 1987-06-22 | 2002-05-16 | Medeva Holdings Bv | Peptido que contiene el antigeno de superficie de la hepatitis b. |
JPH03500408A (ja) * | 1987-09-04 | 1991-01-31 | ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ | 増強された安定性を有するペプチド複合体 |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
GB9325772D0 (en) * | 1993-12-16 | 1994-02-16 | Smithkline Beecham Biolog | Novel compounds |
WO1997039029A2 (en) * | 1996-04-18 | 1997-10-23 | Abbott Laboratories | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
EP2298900A1 (en) | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
AU736032B2 (en) * | 1996-12-30 | 2001-07-26 | Innogenetics N.V. | Annexin V-binding polypeptides derived from HBsAg and their uses |
US6881723B1 (en) | 1998-11-05 | 2005-04-19 | Powderject Vaccines, Inc. | Nucleic acid constructs |
ES2330904B1 (es) | 2005-09-21 | 2010-09-23 | Fundacio Centre De Recerca En Sanitat Animal | Polinucleotidos de haemophilus parasuis y su uso. |
DK2476436T3 (en) | 2006-08-11 | 2018-02-05 | Life Sciences Res Partners Vzw | Immunogenic peptides and their use in immune disorders |
CA2715611C (en) | 2008-02-14 | 2018-03-13 | Life Sciences Research Partners Vzw | Immunotherapy targeting intracellular pathogens |
AU2009214039B2 (en) | 2008-02-14 | 2013-09-19 | Katholieke Universiteit Leuven | Immunogenic control of tumours and tumour cells |
DK2643345T5 (da) | 2010-11-25 | 2021-05-17 | Imnate Sarl | Immunogene peptider til anvendelse til forebyggelse og/eller behandling af infektionssygdomme, autoimmune sygdomme, immunresponser på allofaktorer, allergisygdomme, tumorer, transplantatafstødning og immunresponser på virusvektorer anvendt til genterapi eller genvaccination |
GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
KR101944263B1 (ko) * | 2012-06-11 | 2019-02-01 | 시아먼 유니버시티 | 에이치비브이 감염 및 관련 질병의 치료를 위한 폴리펩타이드 및 항체 |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
JP7090335B2 (ja) | 2015-09-25 | 2022-06-24 | イムサイス エスエー | 治療剤に対する免疫応答を除去するための改善された方法及び化合物 |
WO2017182528A1 (en) | 2016-04-19 | 2017-10-26 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
KR102358577B1 (ko) | 2017-02-17 | 2022-02-04 | 시아먼 유니버시티 | 타겟 폴리펩티드를 제시하는 펩티드 캐리어 및 이의 용도 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
FR2480779B2 (fr) * | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
DD147855A5 (de) * | 1978-12-22 | 1981-04-22 | Biogen Nv | Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids |
US4415491A (en) * | 1980-01-14 | 1983-11-15 | The Regents Of The University Of California | Synthetic vaccine peptide epitomes of hepatitis B surface antigen |
FI83662C (fi) * | 1980-07-17 | 1991-08-12 | Scripps Clinic Res | Diagnostik antikropp och foerfarande foer dess framstaellning. |
IL61904A (en) * | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
EP0082789B1 (en) * | 1981-12-22 | 1987-04-08 | Baylor College of Medicine | Immunological composition and method for hepatitis b virus |
US4483793A (en) * | 1982-10-04 | 1984-11-20 | The Regents Of The University Of California | Dimeric oligopeptides as heptenic epitopic sites for hepatitis |
JPS5974985A (ja) * | 1982-10-19 | 1984-04-27 | Takeda Chem Ind Ltd | 新規dna |
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
-
1985
- 1985-03-06 WO PCT/US1985/000360 patent/WO1985004103A1/en active IP Right Grant
- 1985-03-06 AU AU41159/85A patent/AU579148B2/en not_active Ceased
- 1985-03-07 NZ NZ211356A patent/NZ211356A/xx unknown
- 1985-03-07 DE DE8585301588T patent/DE3586801D1/de not_active Expired - Lifetime
- 1985-03-07 NZ NZ227731A patent/NZ227731A/xx unknown
- 1985-03-07 AT AT85301588T patent/ATE82135T1/de not_active IP Right Cessation
- 1985-03-07 EP EP85301588A patent/EP0155146B1/en not_active Expired - Lifetime
- 1985-03-08 IL IL90035A patent/IL90035A/xx not_active IP Right Cessation
- 1985-03-08 IL IL74545A patent/IL74545A/xx unknown
- 1985-03-08 CA CA000476041A patent/CA1253069A/en not_active Expired
- 1985-11-07 FI FI854396A patent/FI84558C/fi not_active IP Right Cessation
- 1985-11-08 NO NO85854460A patent/NO167359C/no unknown
- 1985-11-08 DK DK516385A patent/DK516385D0/da not_active Application Discontinuation
-
1988
- 1988-12-13 AU AU26823/88A patent/AU623106B2/en not_active Ceased
-
1989
- 1989-04-19 IL IL90035A patent/IL90035A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2682388A (en) | 1989-05-25 |
AU579148B2 (en) | 1988-11-17 |
WO1985004103A1 (en) | 1985-09-26 |
NO167359C (no) | 1991-10-30 |
FI84558B (fi) | 1991-09-13 |
NO854460L (no) | 1986-01-08 |
ATE82135T1 (de) | 1992-11-15 |
CA1253069A (en) | 1989-04-25 |
DE3586801D1 (de) | 1992-12-17 |
NZ211356A (en) | 1990-07-26 |
EP0155146A2 (en) | 1985-09-18 |
EP0155146A3 (en) | 1988-01-20 |
AU623106B2 (en) | 1992-05-07 |
FI854396A0 (fi) | 1985-11-07 |
IL74545A0 (en) | 1985-06-30 |
NO167359B (no) | 1991-07-22 |
IL90035A (en) | 1990-11-05 |
DK516385A (da) | 1985-11-08 |
IL74545A (en) | 1990-11-05 |
EP0155146B1 (en) | 1992-11-11 |
FI84558C (fi) | 1991-12-27 |
NZ227731A (en) | 1990-07-26 |
IL90035A0 (en) | 1989-12-15 |
AU4115985A (en) | 1985-10-11 |
FI854396A (fi) | 1985-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK516385A (da) | Syntetisk vaccine mod hepatitis b virus indeholdende baade t celle og bcelle determinanter | |
LU91498I2 (fr) | Etanercept et ses dérivés pharmaceutiquement acceptables. | |
ES2097878T3 (es) | Fijacion de p53 sobre el adn mediante una secuencia especifica. | |
DE3788475D1 (de) | Verwendung des Rotavirus-Nukleokapsid-VP6-Proteins in Impfstoffzusammensetzungen. | |
DE59504181D1 (de) | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung | |
FI863041A (fi) | Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning. | |
ES555124A0 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
DK235289D0 (da) | Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter | |
DE69230671D1 (de) | Impfstoffe gegen actinobacillus pleuropneumonie | |
FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
DK0584118T3 (da) | Nyt konjugat, bestående af et glycoprotein og en nucleinsyrebindende substans | |
EP0485347A3 (en) | Recombinant hepatitis delta antigen, process for the purification and use thereof | |
IS3511A7 (is) | Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski | |
SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ | |
ES8801127A1 (es) | Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna. | |
ES8801958A1 (es) | Un procedimiento para la determinacion de virus de sida | |
DK381787D0 (da) | Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |